RGNX · Forms 3, 4, 5
Insider trades at REGENXBIO Inc.
1 insider bought $949K of REGENXBIO Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for REGENXBIO Inc. (RGNX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Craig Malzahn | Chief Technology Officer | Tax withholding | 234 | $9.32 | $2K | Form 4 | |
| Mitchell Chan | Chief Financial Officer | Tax withholding | 4,902 | $9.32 | $46K | Form 4 | |
| Gregory Austin Ciongoli | Director | Buy | 53,407 | $9.36 | $500K | Form 4 | |
| Gregory Austin Ciongoli | Director | Became an insider (Form 3) | Form 3 | ||||
| Gregory Austin Ciongoli | Director | Buy | 49,196 | $9.14 | $450K | Form 4 | |
| Gregory Austin Ciongoli | Director | Award | 15,432 | Form 4 | |||
| Steve Pakola | Chief Medical Officer | Tax withholding | 7,468 | $9.69 | $72K | Form 4 | |
| Patrick J. Christmas | Chief Strategy & Legal Officer | Tax withholding | 4,699 | $9.69 | $46K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.